Nomograms for prediction of overall and cancer-specific survival in young breast cancer
Y Sun, Y Li, J Wu, H Tian, H Liu, Y Fang, Y Li… - Breast Cancer Research …, 2020 - Springer
Purpose To assess the prognostic risk factors and establish prognostic nomograms based
on lymph node ratio (LNR) to predict the survival of young patients with breast cancer (BC) …
on lymph node ratio (LNR) to predict the survival of young patients with breast cancer (BC) …
Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort
X Huang, Z Luo, W Liang, G Xie, X Lang, J Gou… - Annals of Surgical …, 2022 - Springer
Background Young breast cancer (YBC) patients are more prone to lymph node metastasis
than other age groups. Our study aimed to investigate the predictive value of lymph node …
than other age groups. Our study aimed to investigate the predictive value of lymph node …
Nomograms to predict the long-term prognosis for non-metastatic invasive lobular breast carcinoma: a population-based study
Y Guan, ST Huang, BB Yu - Scientific Reports, 2024 - nature.com
Invasive lobular breast carcinoma (ILC) is one potential subset that “clinicopathologic
features” can conflict with “long-term outcome” and the optimal management strategy is …
features” can conflict with “long-term outcome” and the optimal management strategy is …
Nomogram Predicting Axillary Lymph Node Dissection Omission After Neoadjuvant Chemotherapy for Node-positive Breast Cancer
H Seki, Y Ishiguro, A Makino, K Yamaguchi… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: To develop an accurate method to predict nodal pathological complete
response (ypN0) in patients after neoadjuvant chemotherapy (NAC) for clinically node …
response (ypN0) in patients after neoadjuvant chemotherapy (NAC) for clinically node …
Development and validation of an extended Cox prognostic model for patients with ER/PR+ and HER2− breast cancer: A retrospective cohort study
Y Xie, X Li, Y Wu, W Cui, Y Liu - World Journal of Surgical Oncology, 2022 - Springer
Background The purpose of this study was to explore a new estrogen receptor (ER) and/or
progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast …
progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast …
A Nomogram to predict overall survival based on the log odds of positive lymph nodes for patients with stage III non-small cell lung cancer
J Shuai, W Huang, YQ Lu - 2022 - researchsquare.com
This study aimed to compare the prognostic efficiency of N stage from the American Joint
Committee on Cancer (AJCC) staging system, lymph nodes ratio (LNR) and log odds of …
Committee on Cancer (AJCC) staging system, lymph nodes ratio (LNR) and log odds of …
[PDF][PDF] Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort
MM Xiao Huang, MM Zhou Luo, MM Wei Liang… - d-nb.info
Background. Young breast cancer (YBC) patients are more prone to lymph node metastasis
than other age groups. Our study aimed to investigate the predictive value of lymph node …
than other age groups. Our study aimed to investigate the predictive value of lymph node …
[PDF][PDF] An Extended Cox Prognostic Model of ER/PR+ and HER2− Breast Cancer Patients
Y XIE, W CUI, Y LIU, X LI - 2020 - assets-eu.researchsquare.com
Background: The purpose of this study was to explore a new ER/PR+ and HER2− breast
cancer prognostic model called the extended Cox prognostic model by us for determining …
cancer prognostic model called the extended Cox prognostic model by us for determining …
[PDF][PDF] Factors predicting non-sentinel lymph node status in breast cancer patients with 1-2 macrometastatic positive sentinel lymph nodes
B Dong, Q Li, M Zhang, W Wu, Y Yao - Int J Clin Exp Med, 2018 - e-century.us
The aim of this study was to investigate predicting factors and to develop a predictive
nomogram for nonsentinel lymph nodes (non-SLNs) metastases in breast cancer patients …
nomogram for nonsentinel lymph nodes (non-SLNs) metastases in breast cancer patients …